Average Co-Inventor Count = 7.52
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (28 from 292 patents)
2. Elmore Patent Law Group, P.c. (1 from 1 patent)
3. Enanta Pharmacueticals, Inc. (1 from 1 patent)
30 patents:
1. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
2. 12018017 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
3. 11976084 - Spiropyrrolidine derived antiviral agents
4. 11834436 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
5. 11560368 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
6. 11555032 - Isoxazole derivatives as FXR agonists and methods of use thereof
7. 11384090 - Spiropyrrolidine derived antiviral agents
8. 11345699 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
9. 11034684 - Isoxazole analogs as FXR agonists and methods of use thereof
10. 11008304 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
11. 10988458 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
12. 10829486 - Isoxazole derivatives as FXR agonists and methods of use thereof
13. 10689391 - Isoxazole analogs as FXR agonists and methods of use thereof
14. 10683279 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
15. 10597391 - Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof